The Discounted Cash Flow (DCF) valuation of Genocea Biosciences Inc (GNCA) is (1,185.13) USD. With the latest stock price at 0.05 USD, the upside of Genocea Biosciences Inc based on DCF is -2356232.5%.
Based on the latest price of 0.05 USD and our DCF valuation, Genocea Biosciences Inc (GNCA) is a sell. selling GNCA stocks now will result in a potential gain of 2356232.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 5.9% | 5.2% |
| Long-term Growth Rate | 3.0% - 4.3% | 3.7% |
| Fair Price | (7,285.90) - (659.72) | (1,185.13) |
| Upside | -14484985.2% - -1311672.3% | -2356232.5% |